Takeshi Sudo

5.1k total citations · 1 hit paper
149 papers, 3.8k citations indexed

About

Takeshi Sudo is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Takeshi Sudo has authored 149 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 102 papers in Oncology, 101 papers in Surgery and 44 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Takeshi Sudo's work include Pancreatic and Hepatic Oncology Research (85 papers), Pancreatitis Pathology and Treatment (47 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (32 papers). Takeshi Sudo is often cited by papers focused on Pancreatic and Hepatic Oncology Research (85 papers), Pancreatitis Pathology and Treatment (47 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (32 papers). Takeshi Sudo collaborates with scholars based in Japan, United States and Russia. Takeshi Sudo's co-authors include Yoshiaki Murakami, Kenichiro Uemura, Taijiro Sueda, Yasushi Hashimoto, Yasuo Hayashidani, Hiroki Ohge, Naru Kondo, Akira Nakashima, Naoya Nakagawa and Ryutaro Sakabe and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Takeshi Sudo

136 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01)

2016 742 citations Katsuhiko Uesaka, Narikazu Boku et al. The Lancet profile →

Peers

Takeshi Sudo

ONCOL

SURGE

PRM

EPIDE

Hiroaki Yanagimoto Japan

Tetsuo Ajiki Japan

Francesco Minni Italy

Yogesh K. Vashist Germany

Ralph H. Hruban United States

Tsuyoshi Sano Japan

Hideo Baba Japan

Yanming Zhou China

Ryosuke Amano Japan

Hiroshi Takamori Japan

Hiroaki Yanagimoto Japan

Takeshi Sudo

1.9k ×0.6

ONCOL

1.2k ×0.5

SURGE

958 ×0.6

PRM

536 ×0.6

EPIDE

308 ×0.6

Citations per year, relative to Takeshi Sudo Takeshi Sudo (= 1×) peers Hiroaki Yanagimoto

Countries citing papers authored by Takeshi Sudo

Since Specialization

Citations

This map shows the geographic impact of Takeshi Sudo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takeshi Sudo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takeshi Sudo more than expected).

Fields of papers citing papers by Takeshi Sudo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takeshi Sudo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takeshi Sudo. The network helps show where Takeshi Sudo may publish in the future.

Co-authorship network of co-authors of Takeshi Sudo

This figure shows the co-authorship network connecting the top 25 collaborators of Takeshi Sudo. A scholar is included among the top collaborators of Takeshi Sudo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takeshi Sudo. Takeshi Sudo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tashiro, Hirotaka, Takashi Onoe, Naoki Tanimine, et al.. (2024). Utility of Machine Learning in the Prediction of Post-Hepatectomy Liver Failure in Liver Cancer. Journal of Hepatocellular Carcinoma. Volume 11. 1323–1330. 5 indexed citations

Yamaguchi, Atsushi, Naohiro Kato, Ryusaku Kusunoki, et al.. (2024). High-grade pancreatic intraepithelial neoplasia diagnosed based on changes in magnetic resonance cholangiopancreatography findings: A case report. World Journal of Clinical Cases. 12(8). 1487–1496.

Uemura, Kenichiro, Naru Kondo, Takeshi Sudo, et al.. (2023). Long‐term outcomes of neoadjuvant gemcitabine, nab‐paclitaxel, and S1 (GAS) in borderline resectable pancreatic cancer with arterial contact: Results from a phase II trial. Journal of Hepato-Biliary-Pancreatic Sciences. 31(5). 351–362. 3 indexed citations

Takada, Masahiro, et al.. (2023). Effects on the Process and Outcome Indicators of the Carbapenem License System and the Full-time Pharmacist Following Meropenem Supply Disruption. Japanese Journal of Infection Prevention and Control. 38(6). 272–277. 1 indexed citations

Ishikawa, Akira, Hiroki Fujii, Kazuhiro Sentani, et al.. (2022). Expression of kinesin family member C1 in pancreatic ductal adenocarcinoma affects tumor progression and stemness. Pathology - Research and Practice. 241. 154277–154277. 8 indexed citations

Sudo, Takeshi, Hirofumi Tazawa, Takahisa Suzuki, et al.. (2022). Micro-lymph node metastasis in intrahepatic cholangiocarcinoma showing pathological complete response to primary tumor and intrahepatic metastasis treated by gemcitabine plus cisplatin chemotherapy and radical surgery. Clinical Journal of Gastroenterology. 16(1). 81–86. 1 indexed citations

Inoue, Masashi, Masahiro Tanemura, Tatsuya Miyamoto, et al.. (2019). A case of hepatic pseudolymphoma in a patient with primary biliary cirrhosis. SHILAP Revista de lepidopterología. 7(10). 1863–1869. 6 indexed citations

Inoue, Masashi, Megumi Yamaguchi, Nobutaka Hatanaka, et al.. (2016). [A Case of Myxofibrosarcoma of the Retroperitoneum].. PubMed. 43(12). 2109–2111.

Uesaka, Katsuhiko, Narikazu Boku, Akira Fukutomi, et al.. (2016). Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01). The Lancet. 388(10041). 248–257. 742 indexed citations breakdown →

10.

Murakami, Yoshiaki, Kenichiro Uemura, Takeshi Sudo, et al.. (2014). Clinicopathological features of 11 resected cases of mucinous cystic neoplasms of the pancreas -Including two cases associated with pregnancy-. Suizo. 29(4). 721–728. 7 indexed citations

11.

Okada, Kenjiro, Yoshiaki Murakami, Kenichiro Uemura, et al.. (2014). Non-functioning pancreatic neuroendocrine tumor with large cystic lesion: A case report. Suizo. 29(1). 91–97. 2 indexed citations

12.

Murakami, Yoshiaki, Kenichiro Uemura, Takeshi Sudo, et al.. (2013). Perineural Invasion in Extrahepatic Cholangiocarcinoma: Prognostic Impact and Treatment Strategies. Journal of Gastrointestinal Surgery. 17(8). 1429–1439. 45 indexed citations

13.

Kobayashi, Hironori, Yoshiaki Murakami, Kenichiro Uemura, et al.. (2012). Human Equilibrative Nucleoside Transporter 1 Expression Predicts Survival of Advanced Cholangiocarcinoma Patients Treated With Gemcitabine-Based Adjuvant Chemotherapy After Surgical Resection. Annals of Surgery. 256(2). 288–296. 39 indexed citations

14.

Murakami, Yoshiaki, Kenichiro Uemura, Takeshi Sudo, et al.. (2011). Intrahepatic Cholangiocarcinoma: Clinicopathological Differences Between Peripheral Type and Hilar Type. Journal of Gastrointestinal Surgery. 16(3). 540–548. 19 indexed citations

15.

Hayashidani, Yasuo, et al.. (2011). A CASE OF COMMUNICATING ACCESSORY BILE DUCT PRESENTED WITH BILIARY INJURY AFTER LAPAROSCOPIC CHOLECYSTECTOMY. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 72(9). 2348–2353.

16.

Sudo, Takeshi, Yoshiaki Murakami, Kenichiro Uemura, et al.. (2011). Distal pancreatectomy with duct-to-mucosa pancreaticogastrostomy: a novel technique for preventing postoperative pancreatic fistula. The American Journal of Surgery. 202(1). 77–81. 19 indexed citations

17.

Murakami, Yoshiaki, Kenichiro Uemura, Takeshi Sudo, et al.. (2011). Prognostic Factors of Patients with Advanced Gallbladder Carcinoma Following Aggressive Surgical Resection. Journal of Gastrointestinal Surgery. 15(6). 1007–1016. 35 indexed citations

18.

Kondo, Naru, Yoshiaki Murakami, Kenichiro Uemura, et al.. (2010). Prognostic Impact of Perioperative Serum CA 19-9 Levels in Patients with Resectable Pancreatic Cancer. Annals of Surgical Oncology. 17(9). 2321–2329. 134 indexed citations

19.

Sudo, Takeshi, Yoshiaki Murakami, Kenichiro Uemura, et al.. (2009). Surgical pancreatic ductal drainage for chronic pancreatitis. Suizo. 24(1). 89–96. 1 indexed citations

20.

Murakami, Yoshiaki, Yujiro Yokoyama, Kenichiro Uemura, et al.. (2005). Successful complete resection of biliary cystadenocarcinoma after percutaneous transhepatic portal embolization. Surgery. 137(5). 577–579. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact